Principal Financial Group Inc T2 Biosystems, Inc. Transaction History

Principal Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.15 - $0.54 $26,667 - $96,003	-177,785 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$0.36 - $0.57 $29,346 - $46,465	-81,518 Reduced 31.44%	177,785 $93,000
Q4 2021 Feb 09, 2022	SELL	$0.46 - $0.94 $206,371 - $421,715	-448,634 Reduced 63.37%	259,303 $134,000
Q3 2021 Nov 09, 2021	SELL	$0.86 - $1.21 $8,437 - $11,871	-9,811 Reduced 1.37%	707,937 $648,000
Q2 2021 Aug 10, 2021	BUY	$1.04 - $1.69 $123,908 - $201,351	119,143 Added 19.9%	717,748 $854,000
Q1 2021 May 10, 2021	BUY	$1.32 - $3.79 $60,160 - $172,733	45,576 Added 8.24%	598,605 $970,000
Q4 2020 Feb 08, 2021	BUY	$1.06 - $1.51 $586,210 - $835,073	553,029 New	553,029 $686,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.